felin
infecti
periton
fip
coronavir
diseas
affect
cat
age
preval
among
cat
year
age
especi
month
age
pedersen
fip
occur
commonli
catteri
pedigre
cat
shelter
kitten
foster
rescu
facil
dens
freeroam
coloni
typic
enzoot
infect
incid
fip
vari
wide
time
mortal
extrem
high
clinic
sign
appear
although
cat
live
diseas
week
month
rare
year
detail
clinic
descript
fip
found
earlier
comprehens
review
cover
herein
addi
et
al
pedersen
drechsler
et
al
fip
viru
fipv
aris
specif
mutat
common
felin
enter
coronaviru
fecv
ubiquit
cat
throughout
world
import
pathogen
pedersen
fecv
shed
fece
appar
healthi
cat
larg
multicat
environ
pedersen
et
al
transmiss
result
direct
ingest
fece
contamin
litter
fomit
kitten
usual
becom
infect
around
week
age
pedersen
et
al
pedersen
et
al
mutant
fecv
capabl
caus
fip
probabl
gener
larg
number
initi
infect
level
fecv
replic
extrem
high
pedersen
et
al
vogel
et
al
howev
small
proport
cat
expos
mutant
virus
develop
fip
resist
fip
complic
involv
genet
suscept
age
time
exposur
number
stressor
occur
time
infect
neg
impact
abil
infect
cat
elimin
viru
time
period
initi
fecv
exposur
clinic
sign
diseas
short
week
long
sever
month
rare
year
period
could
reflect
time
take
mutant
fipv
evolv
diseas
progress
subclin
clinic
state
subclin
infect
usual
limit
mesenter
lymph
node
resolv
progress
pedersen
black
legendr
bartg
pedersen
onset
overt
diseas
signal
cat
battl
viru
lost
return
normal
health
extrem
uncommon
rare
occas
cat
make
appar
recoveri
clinic
sign
recur
month
even
year
later
legendr
bartg
diseas
cours
onset
clinic
sign
death
also
variabl
gener
shorter
younger
cat
cat
effus
diseas
older
cat
cat
noneffus
diseas
cat
even
effus
fip
live
mani
month
author
work
birman
cat
die
dri
fip
year
age
base
extens
clinic
histori
cat
appear
subclin
diseas
entir
life
one
studi
concern
mainli
cat
rel
mild
present
sign
noneffus
diseas
year
surviv
rate
owner
acquir
kitten
young
cat
often
becom
deepli
attach
anim
first
sign
fip
occur
diagnosi
fip
especi
extrem
mortal
rate
lack
effect
treatment
great
psycholog
effect
mani
owner
also
trigger
owner
commun
fear
breeder
shelter
manag
cat
fip
still
reason
well
time
diagnosi
often
live
week
month
longer
symptomat
treatment
owner
might
reluct
accept
diagnosi
fact
effect
treatment
lead
seri
addit
test
often
purport
highli
sensit
specif
seldom
provid
desir
answer
might
even
cloud
diagnosi
lack
effect
therapi
often
complic
matter
owner
go
great
length
research
diseas
internet
sourc
lead
individu
claim
found
treatment
diseas
either
cur
prolong
life
claim
frequent
support
anecdot
statement
owner
found
treatment
benefici
unfortun
due
problem
interpret
avail
diagnost
test
cat
diagnos
fip
actual
diseas
cat
selflimit
condit
fip
appear
respond
well
almost
nonharm
treatment
administ
case
give
credibl
particular
treatment
none
deserv
purpos
review
updat
knowledg
fip
diagnost
therapeut
sinc
subject
last
review
pedersen
number
studi
concern
subject
appear
last
year
knowledg
fip
greatli
increas
howev
still
easi
way
prevent
diseas
simpl
way
diagnos
definit
way
treat
effect
hope
chang
increas
knowledg
factor
caus
fip
drug
target
essenti
step
fip
viral
replic
diagnosi
fip
base
first
foremost
consider
cat
age
origin
clinic
sign
physic
examin
cat
month
age
highdens
environ
manifest
persist
undul
antibiot
unrespons
fever
immedi
suspect
fip
infecti
diseas
fip
signal
specif
sign
fip
observ
owner
physic
examin
narrow
diagnost
choic
even
abdomin
distens
ascit
dyspnea
pleural
effus
jaundic
hyperbilirubinuria
discern
mass
kidney
andor
mesenter
lymph
node
uveiti
rang
neurolog
sign
associ
brain
andor
spinal
cord
involv
common
cat
either
effus
wet
noneffus
dri
form
fip
point
diagnosi
fip
made
reason
certainti
howev
given
high
mortal
mani
veterinarian
owner
feel
uncomfort
diagnosi
base
reason
certainti
difficulti
becom
choos
test
either
increas
odd
clinic
sign
caus
fip
indirect
test
might
provid
definit
diagnosi
direct
test
import
rememb
sensit
specif
indirect
test
vari
greatli
depend
likelihood
cat
fip
base
paramet
say
posit
predict
valu
test
complet
blood
count
cbc
albumin
globulin
g
ratio
predict
fip
far
greater
cat
signal
compat
fip
signal
typic
fip
also
import
mention
result
addit
indirect
test
capabl
confus
diagnost
process
strengthen
diagnosi
fip
usual
achiev
weigh
signal
clinic
find
abnorm
present
common
diagnost
procedur
possibl
postmortem
examin
histopatholog
sharif
et
al
classic
indirect
test
fip
includ
cbc
total
serum
protein
albumin
globulin
level
g
ratio
basic
blood
chemistri
addi
et
al
pedersen
drechsler
et
al
common
abnorm
usual
includ
chronic
nonregen
anemia
anemia
chronic
diseas
leukocytosi
absolut
increas
neutrophil
absolut
decreas
lymphocyt
elev
serum
protein
associ
high
globulin
low
albumin
low
g
ratio
hyperbilirubinemia
hyperbilirubinuria
common
cat
fip
especi
effus
form
elev
serum
urin
bilirubin
biliverdin
usual
associ
elev
liver
enzym
addi
et
al
liver
often
spare
cat
fip
evid
cholestasi
observ
therefor
elev
blood
urin
bilirubin
due
liver
diseas
previous
suggest
rather
due
increas
destruct
rbc
lesion
circul
difficulti
clear
hemoglobin
breakdown
product
cat
notori
poor
glucuronid
court
greenblatt
thu
limit
rate
bilirubin
biliverdin
metabol
recycl
common
abnorm
coupl
usual
signal
clinic
sign
diagnosi
fip
made
high
certainti
even
though
mani
cat
fip
characterist
cbc
albumin
globulin
level
g
reason
expect
everi
target
paramet
alway
abnorm
right
direct
import
look
total
pictur
alway
context
signal
clinic
physic
featur
presenc
characterist
type
fluid
periton
caviti
less
frequent
pleural
caviti
one
diagnost
featur
effus
wet
form
fip
wet
fip
predomin
purebr
random
bred
cat
except
birman
burmes
commonli
diagnos
dri
form
fluid
usual
yellow
ting
due
presenc
bilirubin
rare
greenting
due
presenc
biliverdin
hyperbilirubinemia
hyperbilirubinuria
yellowish
discolor
product
microhemorrhag
breakdown
erythrocyt
macrophag
fip
effus
clear
moder
cloudi
viscou
eggwhit
consist
often
thread
high
protein
near
serum
level
higher
often
form
partial
clot
place
serum
tube
fip
fluid
frequent
label
modifi
transud
base
perceiv
lack
cellular
howev
inflammatori
exud
purest
sens
meet
establish
physic
physiolog
criteria
modifi
transud
zoia
et
al
fip
effus
contain
fair
number
cell
includ
macrophag
neutrophil
low
proport
lymphocyt
fip
effus
usual
outwardli
hemorrhag
appear
except
pleural
effus
howev
often
contain
microscop
number
rbc
visibl
fibrin
tag
exud
fip
unlik
seen
rare
case
bacteri
periton
fluid
accompani
bacteri
periton
clearli
purul
appear
high
neutrophil
count
viscou
yellowting
transud
modifi
transud
associ
liver
heart
diseas
lymphat
duct
ruptur
neoplasia
physic
cellular
characterist
fip
effus
analysi
ascit
pleural
exud
cat
fip
depend
abil
realiz
presenc
effus
obtain
fluid
sampl
simpl
centesi
larg
pleural
periton
effus
often
caus
notic
dyspnea
abdomin
distens
howev
mani
effus
go
unsuspect
initi
physic
examin
minim
volum
case
ultrasonographi
radiolog
employ
identifi
confirm
effus
assist
sampl
collect
radiolog
limit
valu
abdomin
effus
might
sensit
detect
small
amount
pleural
fluid
although
ultrasonographi
radiolog
help
identifi
presenc
fluid
fipspecif
test
ultrasonographi
review
retrospect
cat
reason
confirm
diagnosi
effus
noneffus
fip
lewi
obrien
liver
judg
normal
echogen
cat
diffus
hypoecho
three
cat
focal
hyperecho
one
cat
focal
hypoecho
anoth
five
cat
hypoecho
subcapsular
rim
one
kidney
free
fluid
present
periton
caviti
seven
cat
retroperiton
space
one
cat
abdomin
lymphadenopathi
note
nine
cat
spleen
normal
echogen
cat
hypoecho
two
one
cat
bilater
orchiti
loss
normal
testicular
architectur
author
conclud
none
ultrasonograph
find
specif
fip
find
consid
along
appropri
clinic
sign
rais
level
suspicion
fip
g
ratio
advoc
use
predictor
fip
infect
howev
predict
valu
g
ratio
much
depend
presenc
histor
clinicalphys
laboratori
abnorm
associ
diseas
studi
fip
case
seen
referr
practic
conclud
preval
fip
low
high
g
ratio
use
rule
fip
low
g
ratio
help
make
posit
diagnosi
fip
jefferi
et
al
elev
total
protein
andor
globulin
often
seen
chemistri
panel
cat
fip
absenc
common
laboratori
abnorm
sometim
help
analyz
protein
gel
electrophoresi
determin
exact
caus
elev
taylor
et
al
perform
retrospect
studi
serum
protein
electrophoresi
spe
result
cat
present
univers
bristol
felin
centr
uk
result
met
inclus
criteria
clinic
case
final
diagnosi
classifi
normal
abnorm
serum
protein
electrophoret
pattern
compar
clinic
normal
cat
case
abnorm
serum
electrophoresi
profil
commonli
polyclon
increas
gamma
globulin
common
diseas
classif
associ
serum
protein
abnorm
infectiousinflammatori
diseas
includ
cat
diagnos
fip
monoclon
gammopathi
observ
four
cat
includ
one
fip
one
lymphoma
two
case
splenic
plasmacytoma
major
young
cat
intraocular
neurolog
diseas
noneffus
form
fip
pedersen
ocular
fip
usual
manifest
uveiti
idiopath
uveiti
one
main
differenti
diagnos
wiggan
et
al
compar
two
disord
particularli
diagnost
util
aqueou
humor
cytolog
note
durat
diseas
tend
shorter
cat
fip
idiopath
uveiti
cat
idiopath
uveiti
microbi
nucleic
acid
antigen
antibodi
caus
agent
seldom
found
bloodserum
serum
felin
coronaviru
titer
detect
cat
fip
cytolog
examin
aqueou
humor
plasma
cell
number
correl
kerat
precipit
diseas
durat
expect
clinic
detect
hyphema
correl
erythrocyt
number
correl
cell
number
anterior
chamber
aqueou
flare
although
aqueou
humor
contain
predominantli
neutrophil
cat
fip
larg
reactiv
lymphocyt
plasma
cell
appear
frequent
cat
idiopath
uveiti
neither
clinic
cytolog
assess
anterior
chamber
content
differ
significantli
cat
idiopath
fipassoci
uveiti
involv
brain
brain
spinal
cord
noneffus
fip
well
known
pedersen
howev
sole
involv
spinal
cord
less
commonli
diagnos
anoth
review
record
marionihenri
found
inflammatori
infecti
diseas
fip
commonli
list
caus
felin
myeliti
repres
approxim
case
neoplasm
document
approxim
case
lymphosarcoma
common
cancer
spinal
cord
cat
fip
lymphosarcoma
tend
occur
younger
cat
spinal
diseas
cat
year
age
like
caus
spinal
cord
tumor
intervertebr
disc
diseas
fibrocartilagin
embol
controversi
still
exist
use
interpret
felin
coronaviru
antibodi
titer
serum
plasma
pedersen
main
problem
antibodi
test
fecv
fipv
virtual
ident
evok
antibodi
respons
titer
also
tend
high
among
healthi
cat
environ
foster
fip
felin
coronaviru
antibodi
titer
accur
perform
nonetheless
valu
although
mani
healthi
fecv
expos
cat
titer
indirect
immunofluoresc
assay
pedersen
et
al
mani
cat
fip
likelihood
titer
associ
fip
increas
magnitud
fewer
healthi
cat
titer
titer
highli
suggest
fip
hartmann
et
al
healthi
cat
titer
infrequ
shed
fecv
fece
cat
titer
usual
posit
felin
coronaviru
fece
pedersen
et
al
presenc
low
coronaviru
titer
cat
confirm
fip
alway
problemat
meli
et
al
attempt
explain
discord
investig
whether
viru
blood
effus
cat
bind
antibodi
therebi
lower
antibodi
titer
serumplasma
effus
thirteen
effus
one
plasma
sampl
three
undefin
sampl
cat
fip
unexpectedli
low
serum
coronaviru
antibodi
titer
examin
realtim
revers
transcriptas
rt
pcr
increas
amount
viru
correl
lower
signal
indirect
immunofluoresc
elisa
rapid
immunomigr
antibodi
test
sampl
howev
five
sera
effus
low
coronaviru
antibodi
titer
neg
real
time
rtpcr
presenc
viru
alon
sole
explan
fals
neg
serum
coronaviru
antibodi
test
result
attempt
make
antibodi
test
specif
fipv
attempt
make
pcrbase
test
fipv
specif
classic
test
still
market
antibodi
test
test
develop
faulti
premis
fecv
lack
orf
gene
henc
produc
orf
protein
product
fipv
orf
gene
produc
protein
therefor
also
evok
antibodi
respons
orf
protein
well
known
virtual
field
isol
fipv
fecv
possess
intact
orf
gene
therefor
evok
antiorf
antibodi
fact
relat
antibodi
test
reconfirm
kennedi
et
al
serum
sampl
submit
variou
diagnost
assay
sampl
specificpathogenfre
cat
free
coronaviru
infect
antibodi
test
antibodi
purifi
orf
protein
expect
express
orf
protein
indic
detect
antibodi
protein
found
felin
coronaviru
ie
fecv
fipv
infect
cat
conclud
seroposit
protein
specif
fipv
could
use
diagnos
fip
essenc
antibodi
test
differ
felin
coronaviru
antibodi
test
elisa
popular
antibodi
detect
mani
differ
diseas
disadvantag
compar
indirect
immunofluoresc
antibodi
test
takano
et
al
develop
three
new
immunochromatograph
assay
use
recombin
felin
coronaviru
nucleocapsid
protein
two
three
test
plagu
nonspecif
bind
third
assay
incorpor
protein
blot
step
prove
equal
specif
sensit
standard
elisa
detect
antibodi
plasma
serum
whole
blood
ascit
fluid
presum
simpler
run
agp
use
extens
particularli
europ
indic
test
fip
agp
found
almost
decad
ago
hyposialyl
cat
fip
normal
cat
cat
patholog
ceciliani
et
al
studi
confirm
serum
agp
power
discrimin
marker
fip
coupl
high
risk
factor
paltrinieri
et
al
bayesian
approach
demonstr
pretest
probabl
fip
high
base
histori
clinic
sign
moder
serum
agp
level
could
discrimin
cat
fip
other
howev
high
serum
agp
level
highli
suggest
fip
cat
low
pretest
probabl
diseas
paltrinieri
et
al
giori
et
al
studi
specif
sensit
sever
test
cat
four
confirm
fip
histopatholog
immunohistochemistri
eight
cat
fip
confirm
histopatholog
immunohistochemistri
result
serum
protein
electrophoresi
analysi
effus
antifelin
coronaviru
serolog
serum
agp
concentr
histopatholog
compar
confirm
diagnosi
concord
found
serolog
analysi
effus
poor
concord
note
histopatholog
fair
concord
serum
electrophoresi
perfect
concord
agp
conclus
immunohistochemistri
must
alway
perform
confirm
fip
possibl
histopatholog
definit
elev
agp
concentr
might
support
diagnosi
fip
howev
small
number
cat
studi
make
difficult
valid
conclus
earlier
studi
paltrinieri
et
al
probabl
accur
assess
agp
test
fip
like
indirect
test
fip
posit
predict
valu
increas
number
risk
factor
present
paltrinieri
et
al
also
investig
level
leukocytebound
agp
normal
cat
cat
diseas
includ
fip
flow
cytometri
use
antifelin
agp
antibodi
total
healthi
cat
felin
coronaviru
seroposit
cat
fip
presum
coronaviru
seroposit
cat
diseas
six
coronaviru
seroposit
studi
proport
cat
agpposit
leucocyt
group
cat
differ
intens
inflammatori
respons
measur
cbc
serum
electrophoresi
serum
agp
level
compar
agp
posit
leucocyt
found
cat
diseas
small
number
healthi
agp
posit
leukocyt
stain
associ
inflamm
leukocytosi
per
se
stain
among
healthi
cat
unrel
coronaviru
antibodi
statu
cat
fip
like
posit
stain
leukocyt
healthi
cat
like
cat
diseas
conclud
agp
posit
leucocyt
present
felin
blood
especi
inflamm
stain
leukocyt
agp
bind
appear
valu
serum
agp
test
especi
consid
potenti
cost
effort
involv
method
although
studi
giori
et
al
downplay
reliabl
histopatholog
gross
histolog
lesion
fip
stereotyp
thorough
necropsi
adequ
histopatholog
examin
diseas
tissu
accur
way
confirm
diagnosi
howev
aspect
diseas
veterinari
pathologist
often
reluct
assign
definit
diagnosi
cat
fip
base
see
grossli
microscop
even
though
often
neoplasia
tendenc
describ
found
hope
list
fip
like
caus
lead
immunohistochemistri
definit
diagnosi
made
might
definit
case
rivalta
test
wide
tout
especi
europ
long
use
diagnos
fipassoci
exud
hartmann
et
al
test
involv
place
drop
ascit
thorac
fluid
tube
contain
weak
acet
acid
solut
appear
white
floccul
materi
seen
posit
test
posit
rivalta
test
believ
highli
specif
fip
fluid
studi
cat
effus
confirm
fip
rivalta
test
sensit
specif
posit
predict
valu
neg
predict
valu
fischer
et
al
would
expect
valu
increas
cat
lymphosarcoma
bacteri
infect
exclud
cat
year
age
consid
rivalta
test
appear
reproduc
sampl
store
day
room
refriger
freezer
temperatur
modif
acid
concentr
fischer
et
al
howev
read
test
subject
result
therefor
somewhat
depend
evalu
cat
breeder
test
fecal
sampl
fecv
variou
reason
includ
diagnos
fip
implic
certain
cat
sourc
fip
problem
although
cat
fip
often
shed
fecv
inconsist
viru
shed
lower
level
healthi
cat
felin
coronaviru
case
usual
enter
fip
biotyp
pedersen
et
al
chang
et
al
chang
et
al
applic
test
discourag
odd
signific
proport
cat
catteri
shed
fecv
given
time
high
odd
adult
fecv
shedder
develop
fip
low
evid
howev
higher
proport
cat
catteri
shed
coronaviru
given
time
higher
level
shed
like
fip
occur
popul
foley
et
al
fecal
test
felin
coronavirus
real
time
rtpcr
good
way
detect
shed
also
good
way
quantit
level
frequenc
shed
real
time
rtpcr
commerci
avail
highli
accur
appropri
perform
howev
presenc
inhibitor
need
taken
consider
affect
quantit
measur
viral
level
dye
et
al
larg
amount
viru
shed
fece
mani
week
even
month
initi
infect
time
lack
reexposur
cat
stop
shed
pedersen
et
al
howev
cat
shed
high
level
prolong
period
time
cat
stop
shed
becom
suscept
reinfect
pedersen
et
al
fecv
common
larg
divers
group
enteropathogen
detect
fece
diarrheic
healthi
shelter
cat
enteropathogen
even
weak
statist
associ
diarrhea
sabshin
et
al
even
enter
sign
uncommon
usual
mild
short
live
pedersen
et
al
given
fact
major
shelter
catteri
cat
shed
viru
given
time
coupl
low
intrins
diseas
potenti
littl
need
test
presenc
shelter
catteri
mean
toward
elimin
fecv
premis
thu
lower
chanc
cat
die
fip
howev
without
keep
cat
especi
kitten
number
low
evok
extrem
strict
quarantin
fecv
difficult
rid
premis
easili
reacquir
moreov
establish
maintain
fecv
free
catteri
shelter
run
counter
purpos
facil
even
coronaviru
free
statu
achiev
kitten
environ
ultim
becom
expos
sent
elsewher
new
cat
introduc
although
fecal
test
fecv
product
procedur
predict
valu
know
proport
frequenc
fecal
shedder
greater
proport
frequenc
shed
like
fip
loss
foley
et
al
fecv
shed
also
indirectli
measur
serolog
test
serum
felin
coronaviru
antibodi
level
measur
indirect
immunofluoresc
appear
within
week
infect
titer
around
drop
level
lower
cat
develop
immun
ceas
shed
pedersen
et
al
felin
coronaviru
serolog
also
use
indirect
measur
fecv
shed
cat
antibodi
titer
greater
usual
fecv
shedder
cat
titer
lower
usual
neg
howev
cat
low
neg
antibodi
titer
serum
effus
might
still
contain
consider
viru
fece
effus
great
deal
credenc
place
definit
diagnos
fip
although
author
believ
diagnosi
fip
made
suffici
certainti
base
signal
diseas
sign
physic
examin
result
basic
indirect
test
grim
implic
diagnosi
often
drive
veterinarian
owner
seek
definit
diagnosi
definit
diagnosi
fip
requir
identif
viral
rna
protein
within
macrophag
characterist
lesion
fluid
diseas
tissu
current
two
type
test
avail
definit
diagnosi
identif
viral
protein
immunohistochemistri
identif
viral
rna
sort
test
base
pcr
test
base
pcr
use
help
diagnos
fip
almost
two
decad
li
scott
pcrbase
test
felin
coronavirus
start
purif
rna
fece
blood
tissu
rna
revers
transcrib
complementari
dna
cdna
small
region
cdna
encod
felin
coronavirusspecif
sequenc
amplifi
thousand
time
product
identifi
singl
distinct
band
gel
electrophoresi
refin
made
increas
sensit
specif
pcr
nest
pcr
method
greatli
increas
abil
test
detect
small
amount
felin
coronaviru
rna
cdna
gambl
et
al
nest
pcr
involv
amplifi
larger
fragment
viral
cdna
first
step
purifi
pcr
product
amplifi
smaller
piec
within
larger
amplifi
dna
second
reaction
nest
pcr
reportedli
sensit
specif
detect
fipv
ascit
cat
effus
fip
gambl
et
al
although
sensit
nest
pcr
plagu
dna
contamin
pcr
product
caus
fals
posit
reaction
problem
laboratori
contamin
pcr
product
avoid
use
real
time
rtpcr
reason
virtual
pcrbase
diagnost
test
fecvfipv
rna
base
format
gener
conced
real
time
rtpcr
quit
sensit
specif
detect
semiquantit
fecal
coronaviru
fecv
shed
experiment
natur
infect
cat
pedersen
et
al
pedersen
et
al
kipar
et
al
vogel
et
al
et
al
addi
et
al
amer
et
al
wang
et
al
howev
high
sensit
specif
condit
number
variabl
sampl
must
collect
maxim
viru
content
viral
rna
within
sampl
must
properli
extract
preserv
rna
properli
purifi
revers
transcrib
pcr
inhibitor
usual
fece
must
negat
dye
et
al
reagent
must
properli
design
maintain
activ
form
sampl
properli
run
knowledg
technician
reliabl
instrument
remain
problem
high
degre
viral
genom
divers
affect
bind
primer
use
rtpcr
test
attempt
made
address
design
rtpcr
take
account
degre
genom
variabl
variou
felin
coronavirus
et
al
technic
aspect
although
daunt
overcom
attent
detail
therefor
gener
assum
real
time
rtpcr
sensit
way
detect
coronaviru
rna
fece
diseas
tissueseffus
nevertheless
one
studi
test
accuraci
pcrbase
test
found
accur
confirm
presenc
fipv
diseas
tissu
sharif
et
al
anoth
studi
periton
effus
specimen
cat
suspect
confirm
fip
test
posit
rtpcr
soma
et
al
strang
posit
purebr
vs
mix
breed
cat
even
though
real
time
rtpcr
highli
accur
detect
fecv
fece
fipv
diseas
tissu
fluid
ultim
test
one
detect
fipv
blood
problem
differenti
fecv
rna
fipv
rna
identifi
quit
earli
herrewegh
et
al
base
theori
fecv
found
intestin
replic
form
tissu
test
develop
would
detect
replic
form
felin
coronaviru
rna
ie
subgenom
rna
test
claim
correctli
diagnos
cat
confirm
fip
none
disord
simon
et
al
howev
second
studi
use
procedur
healthi
cat
especi
month
age
rang
also
test
posit
cansahna
et
al
later
explain
experiment
infect
studi
fecv
kipar
et
al
vogel
et
al
demonstr
viremia
accompani
intestin
infect
fecv
identifi
blood
monocytemacrophag
experiment
fecv
infect
cat
day
remain
virem
day
postinfect
fecv
detect
sever
intern
organ
fecal
shed
ceas
kipar
et
al
problem
fecv
coinfect
overcom
design
test
identifi
fipvuniqu
mutat
mutat
orf
gene
cleavag
site
uniqu
fipv
therefor
good
candid
licitra
et
al
pedersen
et
al
fipvspecif
mutat
two
singl
nucleotid
chang
within
fusion
protein
region
spike
surfac
protein
chang
et
al
either
one
mutat
occur
fipv
detect
diseas
tissu
result
report
regard
whether
mutat
present
blood
detect
level
also
possibl
mutat
could
found
healthi
cat
abort
subclin
infect
porter
et
al
even
highli
sensit
specif
fipv
rna
detect
test
could
develop
appear
mani
cat
natur
occur
fip
detect
level
viral
rna
blood
either
within
plasma
concentr
white
cell
fraction
immunostain
diseas
tissu
immunohistochemistri
fluid
immunofluoresc
immunoperoxidas
method
reliabl
rtpcr
accuraci
test
limit
qualiti
reagent
use
tissu
sampl
expertis
microscopist
discern
true
posit
stain
within
macrophag
tissu
lesion
effus
immunofluoresc
sensit
immunoperoxidas
stain
requir
frozen
section
without
glycerolresin
protect
medium
immunoperoxidas
stain
perform
formalin
fix
tissu
formalin
fixat
wax
embed
complet
rapidli
possibl
follow
tissu
collect
although
immunohistochemistri
consid
accur
definit
diagnosi
fip
giori
et
al
case
fip
test
neg
depend
qualiti
tissu
presenc
adequ
lesion
within
materi
examin
qualiti
reagent
test
perform
immunohistochemistri
effus
fluid
cat
suspect
fip
use
much
often
present
effus
often
contain
numer
viru
posit
macrophag
concentr
onto
slide
techniqu
also
use
success
detect
fipv
infect
macrophag
within
cerebrospin
fluid
cat
neurolog
diseas
ive
et
al
nonspecif
posit
stain
macrophag
might
also
problem
litster
et
al
compar
result
direct
immunofluoresc
antemortem
felin
effus
postmortem
result
cat
abdomin
thorac
effus
histopatholog
examin
tissu
collect
necropsi
confirm
fip
case
rule
fip
case
antemortem
direct
immunofluoresc
test
posit
case
confirm
fip
postmortem
examin
seven
cat
fip
rule
postmortem
examin
direct
immunofluoresc
neg
five
case
posit
remain
two
case
calcul
sensit
immunohistochemistri
test
specif
duplic
effus
specimen
eight
cat
initi
posit
immunofluoresc
store
room
temperatur
subject
serial
test
determin
durat
posit
result
direct
immunofluoresc
posit
specimen
store
temperatur
retain
posit
statu
least
day
immunoperoxidas
stain
use
diagnos
fipv
macrophag
skin
two
cat
atyp
skin
lesion
multipl
popular
lesion
declercq
et
al
bauer
et
al
variou
tissu
diseas
mountain
lion
stephenson
et
al
sever
approach
use
treat
cat
fip
proven
approach
viru
infect
eg
human
immunodefici
viru
type
hepat
b
c
virus
use
drug
specif
inhibit
viral
replic
second
approach
inhibit
key
aspect
inflammatori
respons
substanc
interferon
second
approach
rare
work
independ
success
combin
specif
antivir
drug
eg
use
antivir
drug
ribavirin
tenofovir
entecavir
hepat
b
andor
c
viru
infect
third
approach
stimul
immun
system
nonspecif
hope
abl
overcom
infect
approach
combin
one
type
therapi
regardless
approach
use
properli
control
clinic
trial
safeti
efficaci
prerequisit
scientif
public
claim
treatment
fip
hartmann
ritz
antivir
drug
two
basic
type
one
type
target
cellular
machineri
virus
usurp
aid
replic
target
activ
specif
viral
infect
replic
drug
affect
cellular
machineri
least
like
effect
tend
neg
effect
host
viru
success
antivir
therapi
involv
drug
target
specif
region
viral
genom
regul
key
process
infect
replic
felin
coronavirus
sever
gene
similar
activ
includ
rnadepend
polymeras
viral
proteas
retrovir
proteas
anoth
import
target
combin
revers
transcriptas
proteas
integras
inhibitor
effect
reduc
chronic
subclin
infect
patient
base
experi
viral
proteas
inhibitor
similar
drug
develop
main
proteas
encod
coronavirus
norovirus
kim
et
al
mani
structur
protein
coronaviru
first
transcrib
mrna
polyprotein
cleav
proteas
constitu
part
although
cellular
proteas
assum
play
major
role
cleav
fipv
polyprotein
preliminari
vitro
test
show
proteas
inhibitor
effect
inhibit
fipv
replic
level
toxic
cell
kim
et
al
drug
chloroquin
use
treat
malaria
shown
inhibit
fipv
replic
vitro
antiinflammatori
properti
takano
et
al
test
experiment
fip
infect
although
clinic
score
cat
group
treat
chloroquin
better
cat
group
treat
chloroquin
alanin
aminotransferas
level
increas
chloroquinetr
group
indic
untoward
toxic
effect
cyclosporin
also
shown
possess
anticoronaviru
activ
pfefferl
et
al
demonstr
number
immunophilin
strongli
interact
coronaviru
nonstructur
protein
cyclophilin
inhibitor
cyclosporin
block
replic
coronavirus
genera
includ
human
felin
avian
speci
confirm
role
cellular
immunophilin
cyclophilin
coronaviru
replic
author
postul
nonimmunosuppress
deriv
cyclosporin
might
serv
broadspectrum
inhibitor
emerg
human
coronavirus
also
ubiquit
coronaviru
pathogen
human
livestock
abil
cyclosporin
inhibit
felin
coronaviru
replic
cell
cultur
confirm
test
vivo
tanaka
et
al
problem
antivir
agent
chloroquin
cyclosporin
work
pathway
common
cellular
viral
activ
coronavirus
usurp
normal
cellular
pathway
facilit
replic
antivir
effect
compound
chloroquin
cyclosporin
separ
effect
cell
therefor
host
exampl
antivir
activ
chloroquin
vivo
inferior
vitro
activ
toxic
effect
host
takano
et
al
hseih
et
al
screen
compound
antivir
activ
local
felin
coronaviru
strain
feli
catu
whole
cell
hseih
et
al
galanthu
nivali
agglutinin
gna
nelfinavir
proteas
inhibitor
effect
inhibit
felin
coronaviru
replic
level
viru
infect
increas
mimic
target
cell
fipinfect
cat
gna
nelfinavir
longer
inhibitori
howev
two
agent
ad
togeth
fipvinfect
cell
cultur
synergist
effect
observ
viru
replic
inhibit
report
drug
cat
fip
publish
doubt
whether
natur
agglutinin
would
antivir
effect
vivo
wherea
proteas
inhibitor
nelfinavir
tend
viru
specif
raaben
et
al
investig
role
ubiquitinproteasom
system
differ
step
coronaviru
infect
cycl
use
ubiquitin
inhibitor
epoxomicin
velcad
compound
impair
entri
subsequ
rna
synthesi
protein
express
mous
hepat
viru
mhv
fipv
sever
acut
respiratori
syndrom
sar
coronaviru
virion
assembl
releas
judg
mhv
affect
viral
protein
express
reduc
cell
ubiquitin
deplet
use
small
interf
rna
condit
suscept
cell
viru
infect
affect
exclud
import
role
ubiquitin
viru
entri
studi
indic
ubiquitinproteasom
system
involv
multipl
step
coronaviru
infect
cycl
identifi
potenti
drug
target
coronaviru
infect
howev
must
note
ubiquitinproteasom
system
found
involv
replic
cycl
sar
coronaviru
subsequ
studi
leav
uncertainti
involv
mhv
fipv
schneider
et
al
liu
et
al
design
five
overlap
peptid
use
plaqu
reduct
assay
span
heptad
repeat
hr
region
protein
type
ii
fipv
strain
peptid
inhibit
viru
replic
block
intercal
region
necessari
activ
proteinmedi
fusion
abl
inhibit
fipv
replic
use
one
five
peptid
concentr
synergist
effect
found
human
author
conclud
peptid
could
valuabl
addit
current
fip
prevent
method
rememb
use
peptid
vivo
quit
differ
use
vitro
number
drug
antiinflammatori
immunosuppress
activ
prednisolon
alkyl
drug
cyclophosphamid
use
reduc
clinic
sign
cat
fip
evid
alter
diseas
outcom
rather
use
less
specif
therapeut
approach
attempt
made
inhibit
specif
cytokin
deem
import
pathogenesi
fip
tumor
necrosi
factor
tnf
inhibitor
use
time
allevi
sign
fip
one
popular
drug
pentoxyfillin
fischer
et
al
pentoxyfyllin
wide
use
fip
use
control
vascul
human
vascul
import
compon
pathophysiolog
fip
studi
cat
proven
fip
fail
detect
effect
pentoxyfyllin
surviv
time
qualiti
life
fipassoci
clinic
laboratori
paramet
fischer
et
al
use
nonspecif
immunostimul
popular
veterinari
medicin
decad
often
base
purport
efficaci
specif
sign
felin
leukemia
viru
felv
andor
felin
immunodefici
viru
fiv
coinfect
fip
anecdot
report
cat
presum
infect
fip
cure
live
prolong
treatment
includ
immunostimul
staphylococc
protein
immunoregulin
propriobacterium
acn
acemannan
mucopolysaccharid
extract
alo
vera
leav
imulan
lymphocyt
cell
immunomodul
polyprenyl
immunostimul
pi
latest
plant
extract
claim
prolong
live
cat
mild
form
dri
fip
current
rush
use
biolog
agent
base
studi
three
cat
one
reportedli
cure
fip
longterm
treatment
legendr
bartg
howev
three
cat
noneffus
diseas
local
singl
mesenter
lymph
node
two
subclin
diseas
healthi
onset
trial
third
appear
mildli
affect
author
report
treatment
effect
cat
sever
diseas
effus
fip
although
result
provid
point
author
also
fail
consid
cat
local
diseas
could
potenti
undergo
spontan
remiss
subsequ
trial
pi
exclud
cat
effus
fip
cat
sever
diseas
presum
dri
fip
show
surviv
year
therefor
evid
pi
cur
fip
form
evid
significantli
prolong
life
even
cat
mildest
diseas
must
emphas
use
biolog
immun
stimul
treatment
fip
offlabel
condit
licens
licens
use
cat
felv
fiv
infect
case
pi
felin
herpesviru
furthermor
compound
expens
evid
signific
benefit
dosag
regimen
drug
often
uncertain
frequent
base
limit
cost
owner
administ
small
dose
treat
less
frequent
lack
inform
evid
qualiti
pretest
none
immunostimul
subject
vigor
pharmacokinet
bioactiv
studi
although
appear
safe
absenc
adequ
pretest
import
valid
clinic
test
prior
recommend
agent
gener
use
proper
clinic
test
requir
use
placebo
control
random
doubl
blind
suffici
case
number
statist
valid
accur
determin
diseas
statu
also
paradox
mani
veterinarian
use
type
drug
combin
tradit
prednisoneprednisolon
treatment
sinc
one
drug
reportedli
stimul
immun
system
drug
suppress
wild
felid
fip
well
document
virtual
everi
speci
felida
fip
domest
cat
cheetah
histor
intertwin
peark
wilkerson
et
al
initi
studi
genet
divers
among
cheetah
conclud
extrem
inbr
speci
point
accept
skin
graft
inbreed
result
extrem
bottleneck
occur
year
earlier
correct
degre
inbreed
would
made
speci
highli
vulner
introduct
novel
highli
fatal
pathogen
paradigm
thought
realiz
fatal
epizoot
appear
fip
caus
felin
coronaviru
occur
among
captiv
cheetah
winston
safari
park
oregon
usa
earli
outbreak
start
two
confirm
fip
death
among
cheetah
recent
acquir
sacramento
within
month
cheetah
park
fell
ill
retrospect
serum
sampl
test
antibodi
demonstr
prior
cheetah
sera
neg
within
month
arriv
index
case
cheetah
seroconvert
nineti
percent
cheetah
park
becam
ill
next
year
manifest
rang
clinic
sign
weight
loss
diarrhea
jaundic
hepat
renal
diseas
gingiv
ascrib
coronaviru
often
without
firm
evid
conclus
earli
studi
captiv
cheetah
highli
suscept
felin
coronaviru
due
extrem
inbreed
introduct
coronaviru
wild
cheetah
could
catastroph
later
found
incorrect
castroprieto
et
al
test
much
larger
sampl
wild
cheetah
report
much
mhc
class
ii
divers
immun
compet
previous
believ
contradict
previou
specul
cheetah
paradigm
speci
inbreed
vulner
confirm
anoth
manner
studi
felin
coronaviru
infect
wild
captiv
cheetah
gaffney
et
al
cheetah
wild
found
extrem
low
rate
exposur
mani
common
cat
infect
includ
felin
coronaviru
rare
affect
infecti
diseas
howev
almost
half
healthi
captiv
cheetah
shed
felin
coronaviru
fece
persist
transient
intermitt
fip
loss
initi
outbreak
remain
low
therefor
appear
domest
cat
cheetah
handl
felin
coronaviru
similar
manner
although
alreadi
briefli
describ
mountain
lion
puma
puma
concolor
detail
report
fip
california
mountain
lion
recent
publish
stephenson
et
al
epizoot
catarrh
enter
caus
novel
coronaviru
first
describ
pet
ferret
usa
murray
et
al
subsequ
diseas
ident
appear
dri
fip
cat
also
describ
ferret
usa
murray
et
al
caus
viru
epizoot
catarrh
enter
ece
name
ece
viru
ecev
caus
viru
fiplik
diseas
name
ferret
system
coronaviru
frscv
infect
subsequ
report
pet
ferret
japan
europ
michima
et
al
wise
et
al
provacia
et
al
genet
analysi
ecev
frscv
indic
two
coronavirus
close
relat
genet
uniqu
wise
et
al
interestingli
function
mutat
orf
gene
resembl
fipv
seen
frscv
isol
ferret
present
ecev
terada
et
al
detect
coronaviru
fece
pet
ferret
japan
classifi
virus
two
genotyp
base
gene
sequenc
genotyp
relat
frscv
report
wise
et
al
wherea
publish
ece
strain
fell
within
genotyp
resembl
ecev
two
ferret
coronavirus
appear
first
glanc
resembl
fecv
fipv
cat
whether
virus
caus
fiplik
diseas
ece
ferret
inde
genotyp
distinct
spectrum
close
relat
strain
remain
determin
certain
ferret
infecti
periton
rel
new
increas
problem
pet
ferret
hauntingli
similar
appear
fip
first
time
cat
late
pedersen
fact
ferret
coronaviru
exist
sever
genet
form
indic
coronavirus
speci
time
new
ferret
coronaviru
evolv
like
mutat
caus
infecti
periton
ferret
becom
popular
pet
face
risk
factor
face
cat
becam
popular
pet
similar
mutat
respons
system
diseas
felin
ferret
coronavirus
question
remain
unansw
diagnosi
fip
difficult
diseas
mainli
kitten
young
cat
multicat
environ
shelter
catkitten
rescu
organ
catteri
present
histor
physic
sign
whether
effus
noneffus
form
rel
stereotyp
result
routin
cbc
serum
protein
albumin
globulin
determin
often
confirm
suspicion
obtain
histori
physic
examin
yellowting
mucin
inflammatori
periton
pleural
effus
characterist
effus
form
diseas
neurolog
sign
uveiti
mass
ileocecocol
region
kidney
mesenter
lymph
node
characterist
noneffus
form
fip
coronaviru
antibodi
titer
mislead
rang
increasingli
relev
higher
titer
gross
microscop
find
postmortem
examin
often
undervalu
given
greater
import
immunohistochemistri
real
time
rtpcr
use
identifi
fipv
antigen
tissu
lesion
effus
done
properli
provid
definit
diagnosi
holi
grail
fip
diagnost
simpl
blood
test
would
detect
fipv
associ
activ
diseas
fecv
mutant
fecv
yet
capabl
caus
fip
current
effect
treatment
fip
mortal
extrem
high
howev
fact
rare
cat
appear
make
spontan
recoveri
good
support
care
enough
impetu
lead
owner
tri
number
altern
therapi
tout
mainli
internet
mani
therapi
expens
come
high
emot
burden
import
treatment
adequ
test
adequ
number
cat
confirm
diseas
random
placebo
control
doubl
blind
manner
promis
therapi
probabl
involv
drug
specif
target
viral
protein
import
viral
replic
coronavirus
larg
genom
mani
potenti
target
gene
hope
safe
effect
antivir
drug
develop
anticip
drug
might
develop
offshoot
research
investig
emerg
highli
fatal
coronaviru
infect
human
